LMF Acquisition Opp -A -CW26ICUCWPreferred / convertible

13F holders, Q1 2026 (March 31)
10holders −4
1new positions
5sold out
$0.96avg. 13F price*

At the end of Q1 2026, 10 institutions reported holding LMF Acquisition Opp -A -CW26 (ICUCW) in their 13F filings, down 4 from Q4 2025. 1 opened new positions and 5 sold out. The largest holders were Boothbay Fund Management, LLC ($912K), Goldman Sachs Group Inc. ($6K) and Linden Advisors LP ($6K).

Company
LMF Acquisition Opp -A -CW26
Filed as
SEASTAR MEDICAL HOLDING CORP (Q1 2026)
CUSIP
81256L112
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 19Q1 2024Q2 2024: 16Q2 2024Q3 2024: 14Q3 2024Q4 2024: 13Q4 2024Q1 2025: 13Q1 2025Q2 2025: 13Q2 2025Q3 2025: 15Q3 2025Q4 2025: 14Q4 2025Q1 2026: 10Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions1$21
Exits5$2K

All 13F filers, Q4 2025 → Q1 2026: 717 shares bought and 185,430 shares sold, net −184,713 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Boothbay Fund Management, LLC — No change 245,200 $912K
Goldman Sachs Group Inc. — No change 211,381 $6K
Linden Advisors LP — No change 218,073 $6K
LMR Partners LLP — No change 125,000 $4K
Clear Street Group Inc. — Reduce -0.4% 46,490 $1K
TENOR CAPITAL MANAGEMENT Co., L.P. — No change 40,000 $1K
Equitec Proprietary Markets, LLC — No change 35,700 $1K
Cruiser Capital Advisors, LLC — No change 32,473 $935
Wolverine Asset Management LLC — No change 12,281 $354
UBS Group AG — New 717 $21

"% of holder's portfolio" is ICUCW's weight in each manager's 13F, not the share of LMF Acquisition Opp -A -CW26 the manager owns.